$TXG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in 10x Genomics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in 10x Genomics, Inc.. Get notifications about new insider transactions in 10x Genomics, Inc. for free.
Page: < prev 1 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 05 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 100.96 | 300 | 30,289 | 555,991 | 556.3 K to 556 K (-0.05 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 99.62 | 2,532 | 252,242 | 556,291 | 558.8 K to 556.3 K (-0.45 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 99.08 | 4,668 | 462,516 | 558,823 | 563.5 K to 558.8 K (-0.83 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 143,125 | |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 101.31 | 100 | 10,131 | 953,181 | 953.3 K to 953.2 K (-0.01 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 100.63 | 700 | 70,440 | 953,281 | 954 K to 953.3 K (-0.07 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 99.38 | 6,100 | 606,208 | 953,981 | 960.1 K to 954 K (-0.64 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 98.87 | 3,100 | 306,496 | 960,081 | 963.2 K to 960.1 K (-0.32 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 963,181 | 953.2 K to 963.2 K (+1.05 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 540,000 | |
Aug 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 100.76 | 800 | 80,610 | 933 | 1.7 K to 933 (-46.16 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 99.39 | 6,348 | 630,904 | 1,733 | 8.1 K to 1.7 K (-78.55 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 98.85 | 2,852 | 281,916 | 8,081 | 10.9 K to 8.1 K (-26.09 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 10,933 | 933 to 10.9 K (+1,071.81 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 33,750 | 29,700 | 180,000 | |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 101.24 | 600 | 60,746 | 67,500 | 68.1 K to 67.5 K (-0.88 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 100.52 | 2,100 | 211,096 | 68,100 | 70.2 K to 68.1 K (-2.99 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 99.33 | 25,054 | 2,488,669 | 70,200 | 95.3 K to 70.2 K (-26.30 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 98.76 | 5,996 | 592,176 | 95,254 | 101.3 K to 95.3 K (-5.92 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 33,750 | 29,700 | 101,250 | 67.5 K to 101.3 K (+50.00 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 33,750 | 29,700 | 180,000 | |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 101.24 | 600 | 60,746 | 67,500 | 68.1 K to 67.5 K (-0.88 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 100.52 | 2,100 | 211,096 | 68,100 | 70.2 K to 68.1 K (-2.99 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 99.33 | 25,054 | 2,488,669 | 70,200 | 95.3 K to 70.2 K (-26.30 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 98.76 | 5,996 | 592,176 | 95,254 | 101.3 K to 95.3 K (-5.92 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 33,750 | 29,700 | 101,250 | 67.5 K to 101.3 K (+50.00 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 698,000 | |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 100.72 | 1,200 | 120,859 | 963 | 2.2 K to 963 (-55.48 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 99.47 | 8,342 | 829,818 | 2,163 | 10.5 K to 2.2 K (-79.41 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 98.94 | 7,458 | 737,930 | 10,505 | 18 K to 10.5 K (-41.52 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,963 | 963 to 18 K (+1,765.32 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 698,000 | |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 100.72 | 1,200 | 120,859 | 963 | 2.2 K to 963 (-55.48 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 99.47 | 8,342 | 829,818 | 2,163 | 10.5 K to 2.2 K (-79.41 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 98.94 | 7,458 | 737,930 | 10,505 | 18 K to 10.5 K (-41.52 %) |
Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,963 | 963 to 18 K (+1,765.32 %) |
Jul 17 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 90.15 | 100 | 9,015 | 563,491 | 563.6 K to 563.5 K (-0.02 %) |
Jul 17 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 89.17 | 3,626 | 323,325 | 563,591 | 567.2 K to 563.6 K (-0.64 %) |
Jul 17 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 88.52 | 3,774 | 334,086 | 567,217 | 571 K to 567.2 K (-0.66 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 89.08 | 100 | 8,908 | 570,991 | 571.1 K to 571 K (-0.02 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 87.99 | 3,896 | 342,792 | 571,091 | 575 K to 571.1 K (-0.68 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 87.08 | 3,504 | 305,113 | 574,987 | 578.5 K to 575 K (-0.61 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 153,125 | |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 88.88 | 300 | 26,665 | 953,181 | 953.5 K to 953.2 K (-0.03 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 87.99 | 4,500 | 395,947 | 953,481 | 958 K to 953.5 K (-0.47 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 87.16 | 5,200 | 453,228 | 957,981 | 963.2 K to 958 K (-0.54 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 963,181 | 953.2 K to 963.2 K (+1.05 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 550,000 | |
Jul 02 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 88.63 | 100 | 8,863 | 0 | 100 to 0 (-100.00 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 88.03 | 4,779 | 420,695 | 100 | 4.9 K to 100 (-97.95 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 87.18 | 5,121 | 446,439 | 4,879 | 10 K to 4.9 K (-51.21 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 10,000 | 0 to 10 K |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 33,750 | 29,700 | 213,750 | |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 88.67 | 1,211 | 107,379 | 67,500 | 68.7 K to 67.5 K (-1.76 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 87.92 | 18,065 | 1,588,354 | 68,711 | 86.8 K to 68.7 K (-20.82 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 87.11 | 14,474 | 1,260,874 | 86,776 | 101.3 K to 86.8 K (-14.30 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 33,750 | 29,700 | 101,250 | 67.5 K to 101.3 K (+50.00 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 715,000 | |
Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 88.73 | 500 | 44,366 | 0 | 500 to 0 (-100.00 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 87.94 | 8,900 | 782,708 | 500 | 9.4 K to 500 (-94.68 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 87.11 | 7,600 | 662,062 | 9,400 | 17 K to 9.4 K (-44.71 %) |
Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
Jun 18 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 90.13 | 1,057 | 95,267 | 578,491 | 579.5 K to 578.5 K (-0.18 %) |
Jun 18 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 89.48 | 2,648 | 236,948 | 579,548 | 582.2 K to 579.5 K (-0.45 %) |
Jun 18 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 88.63 | 3,795 | 336,344 | 582,196 | 586 K to 582.2 K (-0.65 %) |
Jun 17 2020 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Director | Option Exercise | A | 88.42 | 4,432 | 391,877 | 4,432 | |
Jun 17 2020 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Option Exercise | A | 88.42 | 4,432 | 391,877 | 4,432 | |
Jun 17 2020 | TXG | 10x Genomics, Inc. | Popovits Kimberly J | Director | Option Exercise | A | 88.42 | 4,432 | 391,877 | 4,432 | |
Jun 17 2020 | TXG | 10x Genomics, Inc. | Mammen Mathai | Director | Option Exercise | A | 88.42 | 4,432 | 391,877 | 4,432 | |
Jun 17 2020 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Option Exercise | A | 88.42 | 4,432 | 391,877 | 4,432 | |
Jun 17 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Option Exercise | A | 88.42 | 4,432 | 391,877 | 4,432 | |
Jun 03 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 163,125 | |
Jun 03 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 81.97 | 500 | 40,985 | 953,181 | 953.7 K to 953.2 K (-0.05 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 81.51 | 3,500 | 285,301 | 953,681 | 957.2 K to 953.7 K (-0.37 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 80.14 | 1,100 | 88,149 | 957,181 | 958.3 K to 957.2 K (-0.11 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 79.35 | 1,700 | 134,888 | 958,281 | 960 K to 958.3 K (-0.18 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 78.11 | 2,100 | 164,031 | 959,981 | 962.1 K to 960 K (-0.22 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 77.17 | 1,100 | 84,888 | 962,081 | 963.2 K to 962.1 K (-0.11 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 963,181 | 953.2 K to 963.2 K (+1.05 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 732,000 | |
Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 81.92 | 2,000 | 163,844 | 0 | 2 K to 0 (-100.00 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 81.39 | 4,900 | 398,801 | 2,000 | 6.9 K to 2 K (-71.01 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 80.05 | 2,500 | 200,132 | 6,900 | 9.4 K to 6.9 K (-26.60 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 79.14 | 2,500 | 197,845 | 9,400 | 11.9 K to 9.4 K (-21.01 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 78.06 | 3,400 | 265,420 | 11,900 | 15.3 K to 11.9 K (-22.22 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 77.17 | 1,700 | 131,182 | 15,300 | 17 K to 15.3 K (-10.00 %) |
Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
Jun 01 2020 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Option Exercise | M | 11.48 | 10,000 | 114,800 | 109,167 | |
Jun 01 2020 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Buy | M | 11.48 | 10,000 | 114,800 | 10,000 | 0 to 10 K |
May 22 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 2,156,088 | 0 | 8,790,422 | |
May 22 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Sell | S | 78.00 | 3,100,000 | 241,800,000 | 1,287,825 | 4.4 M to 1.3 M (-70.65 %) |
May 22 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 2,156,088 | 0 | 4,387,825 | 2.2 M to 4.4 M (+96.61 %) |
May 20 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Gift | G | 0.00 | 1,500 | 0 | 953,181 | 954.7 K to 953.2 K (-0.16 %) |
May 14 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,930,198 | 0 | 0 | |
May 14 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | S | 80.13 | 650,000 | 52,084,500 | 2,350,000 | 3 M to 2.4 M (-21.67 %) |
May 14 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | S | 80.13 | 800,000 | 64,104,000 | 3,500,000 | 4.3 M to 3.5 M (-18.60 %) |
May 14 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,930,198 | 0 | 4,300,000 | 2.4 M to 4.3 M (+81.45 %) |
May 08 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,500,000 | 0 | 3,153,528 | |
May 08 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 1,930,198 | |
May 08 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,500,000 | 0 | 3,000,000 | 1.5 M to 3 M (+100.00 %) |
May 08 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 500,000 | 0 | 2,369,802 | 1.9 M to 2.4 M (+26.74 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 9,167 | 46,202 | 173,125 | |
May 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.20 | 833 | 1,000 | 131,250 | |
May 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 78.72 | 2,502 | 196,963 | 954,681 | 957.2 K to 954.7 K (-0.26 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 77.66 | 2,197 | 170,610 | 957,183 | 959.4 K to 957.2 K (-0.23 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 76.65 | 5,301 | 406,339 | 959,380 | 964.7 K to 959.4 K (-0.55 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 9,167 | 46,202 | 964,681 | 955.5 K to 964.7 K (+0.96 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.20 | 833 | 1,000 | 955,514 | 954.7 K to 955.5 K (+0.09 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 570,000 | |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 78.70 | 2,600 | 204,631 | 0 | 2.6 K to 0 (-100.00 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 77.66 | 2,010 | 156,097 | 2,600 | 4.6 K to 2.6 K (-43.60 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 76.64 | 5,390 | 413,110 | 4,610 | 10 K to 4.6 K (-53.90 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 10,000 | 0 to 10 K |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 33,750 | 29,700 | 281,250 | |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 79.20 | 1,120 | 88,705 | 67,500 | 68.6 K to 67.5 K (-1.63 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 78.59 | 8,116 | 637,823 | 68,620 | 76.7 K to 68.6 K (-10.58 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 77.53 | 7,394 | 573,241 | 76,736 | 84.1 K to 76.7 K (-8.79 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 76.62 | 17,120 | 1,311,719 | 84,130 | 101.3 K to 84.1 K (-16.91 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 33,750 | 29,700 | 101,250 | 67.5 K to 101.3 K (+50.00 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 749,000 | |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 79.23 | 300 | 23,769 | 0 | 300 to 0 (-100.00 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 78.66 | 4,200 | 330,370 | 300 | 4.5 K to 300 (-93.33 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 77.57 | 3,695 | 286,634 | 4,500 | 8.2 K to 4.5 K (-45.09 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 76.63 | 8,805 | 674,696 | 8,195 | 17 K to 8.2 K (-51.79 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 570,000 | |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 78.70 | 2,600 | 204,631 | 0 | 2.6 K to 0 (-100.00 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 77.66 | 2,010 | 156,097 | 2,600 | 4.6 K to 2.6 K (-43.60 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 76.64 | 5,390 | 413,110 | 4,610 | 10 K to 4.6 K (-53.90 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 10,000 | 0 to 10 K |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 33,750 | 29,700 | 281,250 | |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 79.20 | 1,120 | 88,705 | 67,500 | 68.6 K to 67.5 K (-1.63 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 78.59 | 8,116 | 637,823 | 68,620 | 76.7 K to 68.6 K (-10.58 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 77.53 | 7,394 | 573,241 | 76,736 | 84.1 K to 76.7 K (-8.79 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 76.62 | 17,120 | 1,311,719 | 84,130 | 101.3 K to 84.1 K (-16.91 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 33,750 | 29,700 | 101,250 | 67.5 K to 101.3 K (+50.00 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 749,000 | |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 79.23 | 300 | 23,769 | 0 | 300 to 0 (-100.00 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 78.66 | 4,200 | 330,370 | 300 | 4.5 K to 300 (-93.33 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 77.57 | 3,695 | 286,634 | 4,500 | 8.2 K to 4.5 K (-45.09 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 76.63 | 8,805 | 674,696 | 8,195 | 17 K to 8.2 K (-51.79 %) |
May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
May 01 2020 | TXG | 10x Genomics, Inc. | Venrock Associates VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,287,825 | 0 | 9,803,991 | |
May 01 2020 | TXG | 10x Genomics, Inc. | Venrock Associates VI, L.P. | 10% Owner | Buy | C | 0.00 | 1,287,825 | 0 | 1,287,825 | 0 to 1.3 M |
May 01 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 1,931,737 | 0 | 10,946,510 | |
May 01 2020 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 1,931,737 | 0 | 2,231,737 | 300 K to 2.2 M (+643.91 %) |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 2,430,198 | |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,000,000 | 0 | 1,869,802 | 869.8 K to 1.9 M (+114.97 %) |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 92,258 | 0 | 327,383 | 235.1 K to 327.4 K (+39.24 %) |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 178,584 | 0 | 0 | 178.6 K to 0 (-100.00 %) |